To further identify the clinical relevance of HAT1 in pancreatic cancer, the survival rate of PDAC patients associated with HAT1 expression was determined through GEPIA web tool and The Human Protein Atlas. This evidence concerns the gene HAT1 and pancreatic neoplasm.